The efficacy of ferulic acid in the treatment of dementia (double-blinded study)
Not Applicable
- Conditions
- Mild Cognitive Impairment
- Registration Number
- JPRN-UMIN000022222
- Lead Sponsor
- Shimane University
- Brief Summary
This trial was done for mild cognitive impairment(MCI). There were not significant difference in MMSE, HDS-R, FAB(frontal assessment battery),hippocampal atrophy (MRI VSRAD) and ADAS-cog between ferulic acid group(n=37) and placebo group(n=41) for one year.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
metabolic encephalopathy(hypothyroidism),head trauma,malignancy,alcohl abuse, mental disorder,chronic renal failure, chronic heart failure,chronic liver injury and patients treated by major tranquilizer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method